Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myelomonocytic, Chronic 1Leukemia, Eosinophilic, Acute 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cytarabine 19Etoposide 7Daunorubicin 7Filgrastim 6tipifarnib 5Idarubicin 5Clofarabine 5Gene Expression Profiling 4Gemtuzumab 4Cyclophosphamide 4Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Flow Cytometry 3Busulfan 3Arsenic Trioxide 3fludarabine phosphate 2aldesleukin 2Thiotepa 2Sorafenib 2Observation 2Melphalan 2Imatinib Mesylate 2Bortezomib 2Asparaginase 2Antilymphocyte Serum 2valspodar 1temsirolimus 1tanespimycin 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Eosinophilic, Acute × palmitoyl-L-asparaginase × Clear all
NCT00369317 2022-01-28

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Children's Oncology Group

Phase 3 Completed
205 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Eosinophilic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡